...
Why us? Why us? please click dropdown
4.8/5 out of 3,500+ reviews
Regulated: CQC Registered | 1-5796078466
  • Verified Content: Approved by the Women’s Health Clinic Clinical Team.
  • Educational Use: This is not a substitute for professional medical advice, diagnosis, or treatment.
  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.
  • MEDICAL EMERGENCY:

    If you need urgent help, use NHS 111. For a life-threatening emergency, call 999.

Author Find more about the author
Dr Farzana Khan

Dr Farzana Khan

Verified

Dr Farzana Khan qualified as an MD from the University of Copenhagen in 2003. She has worked in dermatology and obstetrics & gynaecology across the North of England and completed her MRCGP (CCT, 2013) and the Diploma of the Faculty of Sexual & Reproductive Health (2013). Her clinical focus is vaginal health—including dryness/GSM, sexual function concerns, lichen sclerosus, and comfort or volume changes. She offers careful assessment, discusses medical and conservative options first, and considers selected regenerative or aesthetic treatments where appropriate. Dr Farzana also trains clinicians as a KOL/Trainer with Neauvia, Asclepion Laser, and RegenLab (since 2023). Ongoing CPD includes IMCAS, CCR, ACE and expert training in women’s intimate fillers, PRP, and polynucleotide injectables. Her approach is simple: clear explanations, realistic expectations, and shared decision-making.

MD MRCGP DFFP
Was this answer helpful?
Authored and medically reviewed by Dr Farzana Khan on 12 August 2026
Rate Dr Farzana's explanation



Pelvic floor


Adjunct care


Claims

Women’s Health Clinic FAQ

How does combining a G-Shot with targeted pelvic floor physiotherapy improve overall sexual satisfaction outcomes?

Pelvic-floor physiotherapy or chair-based muscle stimulation should be treated as separate assessment-led care, not as a promise of better G-Shot results.

Direct answer

This page should avoid promising improved satisfaction outcomes and explain that pelvic-floor therapy and G-Shot address different contributors to sexual comfort and function. For patients, pelvic-floor treatment may help support, leakage or muscle symptoms, but it should not be presented as a way to promise G-Shot results or sexual satisfaction. A clinician should assess the symptoms, tissue context and goals before deciding whether any procedure is appropriate, especially when previous treatment, discomfort or expectation mismatch may change the safest plan.

This page keeps a technical treatment question patient-facing, cautious and focused on assessment rather than procedure design.


Educational only. Use this as general education before discussing suitability, timing or symptoms with a clinician. Results vary. Not a cure.

Educational illustration for How does combining a G-Shot with targeted pelvic floor physiotherapy improve overall sexual satisfaction outcomes?

G-Shot review

At a glance

These points frame the question before assuming a combined or repeat treatment is suitable.

Key clinical context

A quick, patient-safe summary before treatment suitability is discussed.

Muscle function matters

Tone, weakness, pain and coordination can influence pressure, comfort and leakage.

Adjuncts are separate

Pelvic-floor treatments have their own aims and evidence limits.

Displacement claims need caution

Movement risk cannot be reduced to a public rule about chair therapy.

Outcomes vary

Sexual satisfaction, comfort and leakage may each need different assessment.

Important safety note

Seek medical advice promptly for severe or worsening pelvic or vulval pain, heavy or persistent bleeding, fever, offensive discharge, urinary retention, spreading swelling, tissue colour change, allergic symptoms, fainting or feeling very unwell.

Pelvic floor
HIFEM
Physio
Support
Review




Detailed answer

Detailed answer

The clinically useful answer explains why this question matters without turning the page into a treatment timetable or protocol.

Clinical bottom line

The decision should be based on symptoms, tissue context, realistic goals and clinician review rather than a public procedural formula.

Evidence
Safety
Consent
Review

Define the purpose

Pelvic-floor symptoms can overlap with questions about sensation, support, pain, urinary leakage and vaginal pressure.

Respect evidence limits

Physiotherapy or HIFEM-style chair treatment should not be marketed as a way to secure filler position or promise sexual outcomes.

Protect expectations

If symptoms suggest pelvic-floor weakness, overactivity, prolapse, pain or urinary problems, those issues may need assessment before any filler decision.

Keep it clinician-led

A patient-facing answer should separate supportive pelvic-floor care from elective augmentation claims.

What this means in practice

The right plan depends on symptoms, tissue health, previous procedures, healing, consent quality and whether a non-procedural route is more appropriate.

Public information can support good questions, but it should not publish injection, machine-parameter, dissolving, sequencing or re-treatment instructions.





Patient safety

Why this matters

These questions can sound technical, but the real issue is safe decision-making and realistic consent.

It protects consent

Combined or repeat treatments need clear reasons, risks and alternatives.

It protects tissue

Filler, energy, hormone and pelvic-floor factors can interact through healing, pressure, swelling and symptoms.

It protects expectations

Sexual response, satisfaction and filler longevity cannot be promised from treatment stacking.

It protects safety

Pain, urinary symptoms, infection signs and tissue change need clear review thresholds.

The safer interpretation

A conservative plan may involve staging, review, deferral or treating another contributing factor first.

This protects patients from over-treatment, unrealistic sexual claims and avoidable complication risk.





Considerations

What a consultation should consider

Consider the treatment goal, tissue quality, menopause or oestrogen context, pain, urinary symptoms, previous procedures, healing, expectations and whether another route should come first.

What changes the decision

Pain, infection symptoms, urinary problems, GSM, previous procedures, healing concerns, distress, surgery plans or unclear goals can all shift the safest next step.

Pelvic floor
HIFEM
Physio
Support

The main goal

The consultation reviews leakage, urgency, pelvic pressure, pain, childbirth history, prolapse symptoms, muscle overactivity and previous pelvic-floor care.

Suitability

The clinician considers whether pelvic-floor physiotherapy, urinary assessment or prolapse review should come before or instead of filler.

Consent

If G-Shot treatment is still discussed, consent should avoid promising improved stability, displacement prevention or satisfaction outcomes.

Follow-up

Follow-up should review comfort, urinary symptoms, pressure, pain and whether pelvic-floor referral remains useful.

Practical expectations

A staged or delayed plan can sometimes be safer than adding another intervention quickly.

Exact procedural details, machine parameters, medicines, dissolving decisions and timing changes should be confirmed with the treating clinician.





Common concerns and myths

Common misconceptions

These myths can make combined or repeat intimate treatment sound more predictable than it is.

Myth: pelvic-floor treatment makes filler stay in place

Reality: filler behaviour and muscle function are separate clinical questions.

Myth: chair therapy plus G-Shot promises satisfaction

Reality: satisfaction is influenced by pain, arousal, relationship context, lubrication and expectations.

Myth: leakage means G-Shot is the answer

Reality: urinary symptoms need their own assessment and care plan.

Symptoms and goals

A symptom pattern can guide assessment, but it does not prove that filler, energy treatment or repeat treatment is the answer.

Public information limits

Public education should support safer decisions without teaching intimate procedures, machine parameters or re-treatment routes.





Safety checklist

Safety checklist

Use these checks before assuming another procedure is the next step.

Is the goal clear?

Clarify whether the aim is sensation, comfort, tissue quality, pelvic-floor support, maintenance, imaging review or repeat treatment.

Has sequencing been reviewed?

Combination or repeat treatment should be staged around healing, symptoms and clinical findings.

Are red flags absent?

Pause and seek clinical review for new bleeding, fever, offensive discharge, severe or worsening pain, urinary symptoms, spreading swelling, tissue colour change, allergic symptoms, persistent lumps, pressure or uncertainty about infection.

Is uncertainty documented?

Consent should explain limited evidence, variable response and possible swelling, bruising, discomfort, urinary symptoms or non-response.

Reassuring signs

Symptoms are more reassuring when mild, stable, improving and not associated with fever, colour change, retention, severe pain or systemic illness.

Pelvic floor
HIFEM
Physio

Reasons to pause

Pause and seek clinical review for new bleeding, fever, offensive discharge, severe or worsening pain, urinary symptoms, spreading swelling, tissue colour change, allergic symptoms, persistent lumps, pressure or uncertainty about infection.

Pain
Urinary
Infection




When to escalate

When to seek medical help

Some symptoms after intimate filler or related treatment need urgent assessment rather than routine follow-up.

Use NHS 111 online

Severe or spreading symptoms

Severe pain, spreading swelling, mottling, blanching, tissue colour change or heavy bleeding should be assessed urgently.

Infection symptoms

Fever, offensive discharge, worsening burning, ulcers, pelvic pain or feeling very unwell may need prompt medical review.

Urinary or allergic symptoms

Inability to pass urine, weak stream, breathing difficulty, facial or throat swelling, widespread rash or collapse needs urgent help.

Emergency symptoms

Call 999 in a life-threatening emergency, including collapse, chest pain, breathing difficulty or sudden neurological symptoms.

Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.

More clinical detail

Why pelvic-floor assessment can change the plan

Weakness, overactivity, pain or prolapse symptoms can make a filler-first approach less appropriate or less helpful.

Why outcome claims should be modest

Support, leakage, sexual comfort and arousal are related but different outcomes. Combining treatments does not make them predictable.

Next step

Book an intimate health consultation

A consultation can clarify whether symptoms fit tissue health, pelvic-floor concerns, GSM, filler-related questions, combination treatment planning, maintenance review or another cause.

View Research Sources (12 Sources)
• NICE urinary incontinence and pelvic organ prolapse guideline
• NHS pelvic organ prolapse
• ISSVD female cosmetic genital surgery recommendations
• GMC decision making and consent
• G-spot systematic review
• ACOG elective female genital cosmetic surgery
• NICE menopause guideline
• NHS vaginal dryness
• FSFI clinical cutoff validation
• JCCP dermal filler complications guidance
• HA filler safety systematic review
• Adverse events in nonsurgical aesthetic procedures systematic review

These 12 source names are selected from 90 curated sources. Additional reviewed material included peer-reviewed clinical papers, evidence reviews, clinical trial records; duplicate and low-relevance records were removed before display.

Educational only. This information is for education only and is not a substitute for professional medical advice, diagnosis or treatment. Results vary. Not a cure.

  • Clinical Assessment: Individual suitability is determined by a clinician; results may vary.
  • Non-NHS: Private healthcare provider only. Pricing varies by treatment and site. Availability varies by clinical location.